from the United States Court of Appeals for the Federal Circuit
See other cases from the Federal Circuit.
Petition DENIED.
Reply of petitioners MSN Pharmaceuticals, Inc., et al. filed. (Distributed)
Brief of respondent Novartis Pharmaceuticals Corporation in opposition filed.
Brief amicus curiae of Public Interest Patent Law Institute filed.
Brief amici curiae of Biophore Pharma, Inc., et al. filed.
Brief amici curiae of Intellectual Property Law Professors filed.
Brief amici curiae of Professor Jonathan Masur, et al. filed.
Brief amicus curiae of Sigmapharm Laboratories, LLC filed.
Brief amicus curiae of Unified Patents, LLC filed.
Motion to extend the time to file a response is granted and the time is extended to and including November 7, 2025.
Motion to extend the time to file a response from October 8, 2025 to November 7, 2025, submitted to The Clerk.
Response Requested. (Due October 8, 2025)
Letter from counsel of MSN Pharmaceuticals, Inc., et al. received.
Brief amicus curiae of Association for Accessible Medicines filed. (Distributed)
Waiver of right of respondent Novartis Pharmaceuticals Corporation to respond filed.
Petition for a writ of certiorari filed. (Response due September 25, 2025)
Application (24A1215) granted by The Chief Justice extending the time to file until August 22, 2025.
Application (24A1215) to extend the time to file a petition for a writ of certiorari from June 23, 2025 to August 22, 2025, submitted to The Chief Justice.
MSN Pharmaceuticals, Inc., et al., Petitioner, represented by Amit R. Vora
Novartis Pharmaceuticals Corporation, Respondent, represented by Deanne Elizabeth Maynard
Biophore Pharma Inc.; Natco Pharma Inc.; and Deva Holding A/S, Amicus Curiae, represented by Shashank S. Upadhye
Intellectual Property Law Professors, Amicus Curiae, represented by Jeffrey Alan Andrews
Professors Jonathan Masur and Lisa Ouellette, Amicus Curiae, represented by David Jacob Zimmer
Public Interest Patent Law Institute, Amicus Curiae, represented by Mark H. Remus
Sigmapharm Laboratories, LLC, Amicus Curiae, represented by Adam G. Unikowsky
The Association for Accessible Medicines, Amicus Curiae, represented by Keith A. Zullow
Unified Patents, LLC, Amicus Curiae, represented by Chad Allen Landmon